NEOGENOMICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neogenomics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Neogenomics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.2M, a 12.4% increase year-over-year.
  • Neogenomics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$92.3M, a 20.1% increase year-over-year.
  • Neogenomics Inc annual Operating Income (Loss) for 2023 was -$108M, a 31.7% increase from 2022.
  • Neogenomics Inc annual Operating Income (Loss) for 2022 was -$158M, a 32.7% decline from 2021.
  • Neogenomics Inc annual Operating Income (Loss) for 2021 was -$119M, a 749% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$92.3M -$21.2M +$3M +12.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$95.3M -$21.9M +$7.95M +26.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$103M -$30.6M +$4.51M +12.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$108M -$18.6M +$7.81M +29.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$116M -$24.2M +$15.3M +38.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$131M -$29.9M +$9.81M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$141M -$35.1M +$17M +32.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 -$158M -$26.4M +$15.2M +36.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$173M -$39.5M +$203K +0.51% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$173M -$39.7M -$17.3M -77.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$156M -$52M -$36.9M -244% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$119M -$41.6M -$47.1M -850% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$71.6M -$39.7M -$44.4M -951% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$27.3M -$22.4M -$3.46M -18.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$23.8M -$15.1M -$9.81M -185% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$14M $5.54M +$3.22M +139% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$17.2M $4.67M +$1.01M +27.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$18.2M -$18.9M -$23.4M -522% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.17M -$5.29M -$7.84M -308% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $13M $2.32M -$500K -17.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $13.5M $3.66M -$261K -6.66% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $13.8M $4.48M +$3.68M +464% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $10.1M $2.55M +$43K +1.72% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $10M $2.82M -$884K -23.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $10.9M $3.92M +$5.98M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $4.94M $794K -$1.05M -56.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $5.99M $2.51M +$3.09M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $2.9M $3.71M +$7.06M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$4.16M -$2.06M -$3.46M -248% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$699K $1.84M -$352K -16.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$347K -$580K -$2.5M -130% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2.16M -$3.36M +$1.86M +35.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $294K $1.4M +$1.28M +1124% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$987K $2.19M +$2.17M +7732% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$3.15M $1.92M +$2.48M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$5.64M -$5.22M -$6.54M -495% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 $900K $114K +$187K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $713K $28K -$550K -95.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $1.26M -$561K -$955K -242% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.22M $1.32M +$115K +9.55% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $2.1M -$73K -$1.23M -106% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $3.34M $578K +$73K +14.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $3.26M $394K +$89K +29.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $3.17M $1.2M +$1.01M +517% Oct 1, 2013 Dec 31, 2013 10-K/A 2016-04-18
Q3 2013 $2.17M $1.16M +$1.84M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $321K $505K -$334K -39.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $655K $305K -$556K -64.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $1.21M $195K -$179K -47.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $1.39M -$684K -$726K -1729% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $2.12M $839K +$953K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $1.16M $861K +$1.57M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$409K $374K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $42K +$1.05M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$114K +$683K +85.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-15
Q1 2011 -$711K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$1.01M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 -$797K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.